Skip to content
Experimentica
  • Our solutions
    • Disease models
    • Our expertise
    All our solutions
    • Diabetic Retinopathy
      • Oxygen-Induced Retinopathy
      • Streptozotocin-Induced Diabetic Retinopathy
    • Dry AMD, Geographic Atrophy
      • Blue Light Damage-induced Retinal Degeneration
      • Laser-Induced Geographic Atrophy
      • Sodium Iodate-Induced Retinal Degeneration
      • White Light Damage-induced Retinal Degeneration
    • Dry Eye
      • Desiccating Stress + Scopolamine-Induced Dry Eye
    • Functional assessment
      • Flash Electroretinography
      • Pattern Electroretinography
      • Visual Evoked Potentials
    • Glaucoma
      • Optic Nerve Crush
      • Microbead-Induced Glaucoma
      • Laser-Induced Glaucoma
    • In vivo imaging and AI analysis
      • In vivo imaging
      • AI for image analysis
    • Molecular biology
      • RT-qPCR
      • Western Blotting
      • ELISA
    • Multiple Sclerosis
      • Experimental Autoimmune Encephalomyelitis
    • Permeability
      • In vitro permeability
    • Retinal Ischemia
      • High IOP-induced ischemia-reperfusion injury
      • Nonarteritic Anterior Ischemic Optic Neuropathy
    • Retinitis Pigmentosa
      • Retinitis Pigmentosa
    • Tissue processing and histology
      • Tissue processing
      • Histological staining
      • Immunohistochemistry
    • Uveitis
      • Antigen-Induced Uveitis
    • Visual acuity and contrast sensitivity
      • Optomotor Reflex
    • Wet AMD
      • Oxygen-Induced Retinopathy
      • Laser-induced Choroidal Neovascularization
      • DL-AAA–Induced Retinal Neovascularization and Chronic Leakage
      • High IOP-induced ischemia-reperfusion injury
      • In vitro tube formation assay (HUVECs)
  • About us
    • Our team
    • Animal welfare
    • R&D projects
  • Studies
    • Toxicity
    • Pharmacokinetics
    • Gene therapy
    • Pharmacology & Efficacy
  • News
  • Contact us

Kon’nichiwa BioJapan 2024!

Events

06.10.2024

All News
Experimentica will be presenting preclinical ocular models at BioJapan 2024 in Yokohama, Oct. 9-11, 2024.
Kon’nichiwa BioJapan 2024!

Our team is setting the course towards Asia’s largest pharma and biotech partnering event, BioJapan 2024, October 9-11, 2024.

Our CEO Dr. Giedrius Kalesnykas and CBO Dr. Guillaume Demarne will be presenting Experimentica’s preclinical models and the latest R&D projects. Book a meeting or swing by our booth #D-13 to learn more. We can’t wait to meet you!

Find out more


Wet AMD models
Dry AMD models
Glaucoma models
PK studies
Tox studies
Animal welfare at Experimentica

Latest Activity

Check out our latest news and activities

All Events
ARVO 2025

Events

28.04.2025

ARVO 2025
The 8th Gene Therapy Summit in Boston – let’s connect!

Events

20.03.2025

The 8th Gene Therapy Summit in Boston – let’s connect!
Experimentica is heading to BIO-Europe Spring 2025 in Milan

Events

13.03.2025

Experimentica is heading to BIO-Europe Spring 2025 in Milan
Meet Us at Bio-Europe 2024!

Events

03.11.2024

Meet Us at Bio-Europe 2024!
AAALAC accredited company

All our facilities are AAALAC accredited, reflecting our commitment to the highest standards of animal care in research.

AAALAC International
Experimentica

Experimentica Ltd. is a contract research organization (CRO) providing preclinical ocular models and services to pharmaceutical, biotech, and academic clients.

  • Home
  • Our solutions
  • Studies
  • News
  • About us
  • Animal welfare
  • Privacy policy
  • Contact us

Finland

Headquarters and laboratories

Microkatu 1, P.O. Box 1199

70211 Kuopio, Finland

Lithuania

R&D unit and laboratories

Vismaliukų g. 32, K25A

10243 Vilnius, Lithuania

France

Global BD office

113, Rue de la République
13013 Marseille, France

USA

Toll free

+1 844 393 4393 (EYE-4-EYE)

Copyright: Experimentica Ltd. 2025